rs118204450
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The ENST00000374479.4(FUCA1):c.1279C>T(p.Gln427Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q427Q) has been classified as Likely benign.
Frequency
Consequence
ENST00000374479.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FUCA1 | NM_000147.5 | c.1279C>T | p.Gln427Ter | stop_gained | 8/8 | ENST00000374479.4 | NP_000138.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FUCA1 | ENST00000374479.4 | c.1279C>T | p.Gln427Ter | stop_gained | 8/8 | 1 | NM_000147.5 | ENSP00000363603 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251356Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135844
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727230
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
Fucosidosis Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1989 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change creates a premature translational stop signal (p.Gln427*) in the FUCA1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 40 amino acid(s) of the FUCA1 protein. This variant is present in population databases (rs118204450, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with fucosidosis (PMID: 8401503). It has also been observed to segregate with disease in related individuals. This variant is also known as Q422X. ClinVar contains an entry for this variant (Variation ID: 681). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 06, 2017 | Variant summary: The FUCA1 c.1279C>T (p.Gln427X) variant results in a premature termination codon, predicted to cause a truncated or absent FUCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant was found in 2/121354 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic FUCA1 variant (0.001118). This variant has been reported in multiple affected individuals with FUCO. In addition, the fibroblast from patients showed negligible enzyme activity and very low CRIM level for a-L-fucosidase (Seo_1993). Taken together, this variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at